摘要:
Pharmaceutical compositions are described containing a long pentraxin PTX3, particularly human PTX3, for the therapy of infectious and inflammatory or tumor diseases; expression vectors containing cDNA coding for PTX3; recombinant host cells transfected with such vectors; a method for producing substantial amounts of PTX3 involving the culturing of such cells, and the use of said vectors in the gene therapy of tumors.
摘要:
The present invention relates to a peptide capable of binding to ICE and/or to enzymes of the ICE family, which peptide consists essentially of the amino acid sequence of SEQ ID NO:1 reported in the Sequence Listing, in which Xaa is selected between Asp and Ala, optionally containing one or more amino acids at its N-terminal and/or C-terminal end. It also relates to the use of the above peptide, for the preparation of pharmaceutical compositions active in pathologies requiring ICE inhibition and/or inhibition of enzymes of the ICE family.
摘要翻译:本发明涉及能够结合ICE和/或ICE家族的酶的肽,该肽基本上由序列表中报道的SEQ ID NO:1的氨基酸序列组成,其中Xaa选自Asp 和Ala,任选在其N-末端和/或C-末端含有一个或多个氨基酸。 它还涉及上述肽用于制备在需要ICE抑制和/或抑制ICE家族酶的病态中活性的药物组合物的用途。
摘要:
It is described the use of antibodies against exogenous surface antigens not present on normal human T lymphocytes for the preparation of compositions for the treatment of the graft versus host disease in patients who have received T lymphocytes transduced with such exogenous surface antigens.